0000899243-23-007801.txt : 20230309 0000899243-23-007801.hdr.sgml : 20230309 20230309213507 ACCESSION NUMBER: 0000899243-23-007801 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181116 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wood Susan Alyson CENTRAL INDEX KEY: 0001757291 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09341 FILM NUMBER: 23721456 MAIL ADDRESS: STREET 1: 845 MORENO AVENUE CITY: PALO ALTO STATE: CA ZIP: 94303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICAD INC CENTRAL INDEX KEY: 0000749660 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 020377419 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 98 SPIT BROOK ROAD, SUITE 100 CITY: NASHUA STATE: NH ZIP: 03062 BUSINESS PHONE: 603-882-5200 MAIL ADDRESS: STREET 1: 98 SPIT BROOK ROAD, SUITE 100 CITY: NASHUA STATE: NH ZIP: 03062 FORMER COMPANY: FORMER CONFORMED NAME: HOWTEK INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-16 0 0000749660 ICAD INC ICAD 0001757291 Wood Susan Alyson C/O ICAD, INC. 98 SPIT BROOK ROAD, SUITE 100 NASHUA NH 03062 1 0 0 0 Director Stock Option (right to buy) 2.89 2018-11-16 4 D 0 40000 D 2023-11-16 Common Stock 40000 0 D Director Stock Option (right to buy) 2.89 2023-03-07 4 A 0 40000 A 2028-11-16 Common Stock 40000 40000 D Director Stock Option (right to buy) 3.70 2018-12-31 4 D 0 8738 D 2023-12-31 Common Stock 8738 0 D Director Stock Option (right to buy) 3.70 2023-03-07 4 A 0 8738 A 2028-12-31 Common Stock 8738 8738 D The two reported transactions involved an amendment to an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 16, 2018 and is fully vested as of the date hereof. The two reported transactions involved an amendment to an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 31, 2018 and is fully vested as of the date hereof. On March 7, 2023, the Board of Directors of the Issuer agreed to a modification of the exercise period for certain outstanding stock options granted to the Director in 2018 that would otherwise expire in November 2023 such that they now have an aggregate exercise period of ten years. No other modification was made to the option. /s/Susan Wood 2023-03-09